ELYM - Eliem Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $6.13. This is a potential upside of $3.04 (98.38%) from yesterday's end of day stock price of $3.09.

Eliem Therapeutics's activity chart (see below) currently has 12 price targets and 13 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 45.83% with an average time for these price targets to be met of 381.5 days.

Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 07-Mar-2023. First documented stock forecast 06-Sep-2021.

Best performing analysts who are covering ELYM - Eliem Therapeutics:

Marc Goodman Douglas Tsao Paul Matteis Yatin Suneja

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$6

$2.91 (94.17%)

2 years 7 months 19 days ago
(07-Mar-2023)

2/2 (100%)

$2.36 (64.84%)

485

Buy

$4

$0.91 (29.45%)

$9

3 years 2 months 11 days ago
(15-Aug-2022)

2/4 (50%)

$1.11 (38.41%)

402

Buy

$8

$4.91 (158.90%)

3 years 2 months 25 days ago
(01-Aug-2022)

1/3 (33.33%)

$5.28 (194.12%)

639

Hold

$32

3 years 6 months 1 days ago
(25-Apr-2022)

0/1 (0%)

$3.39 (11.85%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ELYM (Eliem Therapeutics) average time for price targets to be met?

On average it took 381.5 days on average for the stock forecasts to be realized with a an average price target met ratio 45.83

Which analyst has the current highest performing score on ELYM (Eliem Therapeutics) with a proven track record?

MARC GOODMAN

Which analyst has the current lower performing score on ELYM (Eliem Therapeutics) with a proven track record?

YATIN SUNEJA

Which analyst has the most public recommendations on ELYM (Eliem Therapeutics)?

Marc Goodman works at LEERINK and has 9 price targets and 7 ratings on ELYM

Which analyst is the currently most bullish on ELYM (Eliem Therapeutics)?

Paul Matteis with highest potential upside - $4.91

Which analyst is the currently most reserved on ELYM (Eliem Therapeutics)?

Yatin Suneja with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?